Workflow
微芯转债
icon
Search documents
29日投资提示:申昊科技:预计2025年亏损2.2亿至1.85亿
集思录· 2026-01-28 13:53
Group 1 - YuXing Co., Ltd. is expected to incur a loss of between 290 million to 220 million yuan in 2025 [1] - ShenHao Technology is projected to have a loss ranging from 220 million to 185 million yuan in 2025 [1] - Hongqiang Co., Ltd. anticipates a loss of between 32 million to 48 million yuan in 2025 [1] - Fengshan Group expects a profit of between 32.6 million to 48.6 million yuan in 2025, marking a turnaround from previous losses [1] Group 2 - The convertible bond market shows various bonds with current prices and redemption values, indicating potential investment opportunities [2][4][6] - Specific convertible bonds such as Huanxu Convertible Bond and Fulong Convertible Bond have current prices of 163.745 and 136.554 respectively, with redemption prices indicating potential gains [2] - The premium rates for several convertible bonds, such as Weixin Convertible Bond at 41.74%, suggest varying levels of attractiveness for investors [6]
深圳微芯生物科技股份有限公司关于“微芯转债”预计满足赎回条件的提示性公告
Core Viewpoint - Shenzhen Chipscreen Biosciences Co., Ltd. has announced that its convertible bond, "Chipscreen Convertible Bond," is expected to meet the redemption conditions based on the stock price performance during a specified period [2][8]. Group 1: Convertible Bond Issuance Overview - The company issued 5 million convertible bonds with a total value of RMB 500 million, each with a face value of RMB 100, approved by the China Securities Regulatory Commission on July 5, 2022 [3]. - The bonds have a maturity period of six years, from July 5, 2022, to July 4, 2028, and began trading on the Shanghai Stock Exchange on July 28, 2022, under the name "Chipscreen Convertible Bond" with the code "118012" [3]. Group 2: Redemption Terms and Expected Trigger Conditions - The redemption terms include a mandatory redemption at 115% of the face value plus the last interest payment within five trading days after maturity [5]. - Conditional redemption can occur if the stock price remains at or above 130% of the conversion price for at least 15 out of 30 trading days or if the remaining unconverted bonds are less than RMB 30 million [6][8]. - As of January 22, 2026, the stock price has been above 130% of the conversion price for 10 trading days, and if this trend continues, the company may decide to redeem the bonds [2][8].
中证转债指数午盘上涨0.68%
Mei Ri Jing Ji Xin Wen· 2026-01-21 03:42
Core Viewpoint - The China Convertible Bond Index rose by 0.68% to 521.83 points on January 21, indicating a positive market trend in convertible bonds [1] Group 1: Top Gainers - Tianchuang Convertible Bond increased by 20.00%, leading the gains [1] - Dazhong Convertible Bond rose by 10.55% [1] - Zhejiang Mining Convertible Bond saw an increase of 10.33% [1] - Weichip Convertible Bond grew by 9.69% [1] - Hongqiang Convertible Bond experienced a rise of 6.63% [1] Group 2: Top Losers - Huanxu Convertible Bond decreased by 2.77%, marking the largest drop [1] - Shentong Convertible Bond fell by 2.22% [1] - Libo Convertible Bond declined by 1.81% [1] - Fuxin Convertible Bond dropped by 1.14% [1] - Heshun Convertible Bond saw a decrease of 1.13% [1]
中证转债开盘基本持平。通光转债涨近6%,奇正转债、微芯转债涨超4%,海亮转债涨近3%;应急转债涨超10%,宏丰转债涨超3%,景23转债涨2.5%。
news flash· 2025-08-01 01:29
Group 1 - The overall market for convertible bonds opened flat, indicating stability in the sector [1] - Tongguang Convertible Bond increased by nearly 6%, showing strong investor interest [1] - Qizheng Convertible Bond and Weichip Convertible Bond both rose over 4%, reflecting positive market sentiment [1] Group 2 - Hailiang Convertible Bond saw an increase of nearly 3%, contributing to the overall positive performance [1] - Emergency Convertible Bond surged over 10%, indicating significant demand [1] - Hongfeng Convertible Bond and Jing23 Convertible Bond rose by over 3% and 2.5% respectively, further highlighting the upward trend in the market [1]
深圳微芯生物科技股份有限公司关于不提前赎回“微芯转债”的公告
Group 1 - The company has decided not to exercise the early redemption rights for the "Microchip Convertible Bonds" despite meeting the conditions for conditional redemption [2][8][9] - The stock price of the company met the requirement of being at least 130% of the current conversion price (32.838 CNY/share) for at least 15 out of 30 trading days from July 11 to July 31, 2025, triggering the conditional redemption clause [2][7] - The board of directors held a meeting on July 31, 2025, to review and approve the decision not to redeem the bonds early, citing confidence in the company's sustainable development and intrinsic value [8][9][10] Group 2 - The company issued 5 million convertible bonds with a total amount of 500 million CNY, which are set to mature in six years from July 5, 2022, to July 4, 2028 [3][4] - The initial conversion price was set at 25.36 CNY/share, which was adjusted to 25.26 CNY/share on June 4, 2024, due to share buybacks and reductions in total share capital [4] - The redemption terms state that the company can redeem the bonds at 115% of the face value after maturity or under certain conditions during the conversion period [5][6]
微芯生物: 国投证券股份有限公司关于深圳微芯生物科技股份有限公司不提前赎回“微芯转债”的核查意见
Zheng Quan Zhi Xing· 2025-07-31 16:15
Summary of Key Points Core Viewpoint - The company has decided not to exercise the early redemption rights for its convertible bonds, "微芯转债," based on confidence in its sustainable development and intrinsic value, considering various factors including market conditions and investor expectations [4]. Group 1: Convertible Bond Issuance Overview - The company issued convertible bonds with a total amount of RMB 500 million, with a maturity period of six years from July 5, 2022, to July 4, 2028 [1]. - The initial conversion price for the bonds is set to be adjusted to RMB 25.26 per share starting from June 4, 2024 [2]. Group 2: Redemption Terms and Conditions - The redemption terms state that the company can redeem the bonds at 115% of the face value if the stock price exceeds 130% of the conversion price for at least 15 out of 30 consecutive trading days, or if the remaining balance of the bonds is less than RMB 30 million [2][3]. - The conditional redemption terms were triggered between July 11, 2025, and July 31, 2025, as the stock price met the required threshold [3]. Group 3: Decision-Making Process - The company's board of directors approved the decision not to redeem the bonds early during a meeting held on July 31, 2025, emphasizing the company's confidence in its future [4]. - The company will not propose a conditional redemption plan even if the redemption conditions are met again within three months following the decision [4]. Group 4: Stakeholder Trading Activity - There has been no trading of the convertible bonds by major stakeholders, including the actual controller, significant shareholders, and senior management, within six months prior to the redemption condition being met [4]. Group 5: Sponsor's Verification Opinion - The sponsor institution has verified that the decision not to redeem the bonds early has followed the necessary decision-making procedures and complies with relevant regulations and agreements [6].
微芯生物: 关于不提前赎回“微芯转债”的公告
Zheng Quan Zhi Xing· 2025-07-31 16:15
Core Viewpoint - Shenzhen Microchip Biotech Co., Ltd. has decided not to exercise the early redemption rights for its convertible bonds, despite triggering the conditional redemption clause due to stock prices exceeding 130% of the conversion price for 15 trading days [1][3]. Group 1: Conditional Redemption Trigger - The company's stock price has met the condition for the conditional redemption of the convertible bonds, with a closing price not lower than 32.838 CNY per share for at least 15 out of 30 trading days [1][3]. - The company will not propose a conditional redemption plan for the next three months, even if the redemption conditions are triggered again [2][4]. Group 2: Convertible Bond Issuance Overview - The company issued convertible bonds totaling 500 million CNY, with a maturity of six years from July 5, 2022, to July 4, 2028 [2]. - The initial conversion price was set at 25.36 CNY per share, adjusted to 25.26 CNY per share as of June 4, 2024, due to share repurchase and cancellation [2][3]. Group 3: Redemption Terms and Procedures - The redemption terms state that the company can redeem the bonds at 115% of the face value if the stock price conditions are met or if the remaining bond balance is below 30 million CNY [3][4]. - The board of directors convened on July 31, 2025, to review and approve the decision not to redeem the bonds early, considering the company's sustainable development and market conditions [4][5]. Group 4: Stakeholder Trading Restrictions - Major stakeholders, including the actual controller and significant shareholders, have not traded the convertible bonds within the six months leading up to the redemption condition being met [5]. Group 5: Sponsor's Verification Opinion - The sponsor has confirmed that the decision not to redeem the convertible bonds has followed necessary decision-making procedures and complies with relevant regulations [5].
8月1日投资提示:ST应急复牌
集思录· 2025-07-31 14:28
Group 1 - The company Shanying International has changed its name from Shanying Paper, which raises questions about the reasoning behind the rebranding while still referring to itself as Shanying Paper in announcements [1] - China Shipbuilding Emergency's 2022 annual report revealed accounting errors, leading to an overstatement of revenue by 31.37 million yuan, which is 1.86% of the reported revenue, and an overstatement of profit by 7.14 million yuan, which is 36.64% of the reported profit [1] Group 2 - Shanying International plans to establish a partnership enterprise with a valuation of 2.977 billion yuan, aiming to attract long-term investors such as China Orient Asset Management and others, which will enhance its sustainable development and core competitiveness [2]
微芯生物:关于不提前赎回“微芯转债”的公告
Zheng Quan Ri Bao· 2025-07-31 13:43
Group 1 - The company announced that it will not exercise the early redemption rights for the "Microchip Convertible Bonds" [2] - The decision was made during the 12th meeting of the third board of directors held on July 31, 2025 [2]
注意!操作不当将巨亏 逾10只可转债即将强赎!
Group 1 - A significant number of convertible bonds, exceeding 10, are facing mandatory redemption, prompting investors to pay attention to the last trading days and conversion details to avoid losses [1][2][3] - Companies such as China Shipbuilding Emergency, Lian De Equipment, and Chu Jiang New Materials have issued announcements regarding the early redemption of their convertible bonds, with specific redemption prices and deadlines outlined [2][4] - The last trading day for Bei Lu Convertible Bond is set for July 30, 2025, with a mandatory redemption price of 101.64 yuan per bond if not converted by August 4, 2025, leading to a potential loss of 23.58% for investors who do not convert [3][4] Group 2 - Most of the convertible bonds scheduled for mandatory redemption will reach their last trading days and conversion days in August 2025, requiring investors to closely monitor these timelines [4] - The redemption prices for the identified convertible bonds are generally above 110 yuan per bond, with some exceeding 150 yuan, indicating a risk of significant losses if investors fail to act in time [4] - Some companies, such as Microchip Biotech and Tongguang Cable, have opted not to redeem their convertible bonds early, citing conditions met for redemption but choosing to retain the bonds instead [7][8]